Shenda M Baker Selected Research

arginyl)glucosamine poly-N (acetyl

1/2018

In Vitro activity of novel glycopolymer against clinical isolates of multidrug-resistant Staphylococcus aureus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shenda M Baker Research Topics

Disease

4	Infections 01/2022 - 01/2017
2	Dehydration (Water Stress) 11/2023 - 01/2019
2	Cystic Fibrosis (Mucoviscidosis) 01/2022 - 01/2017
1	Lung Diseases (Lung Disease) 11/2023
1	Inflammation (Inflammations) 01/2022
1	Cicatrix (Scar) 02/2013
1	Burns 02/2013
1	Wounds and Injuries (Trauma) 02/2013
1	Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature 12/2006
1	Metrorrhagia (Spotting) 12/2005

Drug/Important Bio-Agent (IBA)

4	Pregnancy-Associated alpha 2-Macroglobulins (alpha 2 Macroglobulin)IBA 11/2023 - 01/2017
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2019 - 01/2017
1	SodiumIBA 11/2023
1	Glucosamine (Dona)IBA 01/2022
1	Expectorants (Mucolytics)IBA 01/2022
1	MucinsIBA 01/2019
1	Virulence Factors (Pathogenicity Factors)IBA 01/2019
1	arginyl)glucosamine poly-N (acetylIBA 01/2018
1	Meropenem (Merrem)FDA LinkGeneric 01/2017
1	Tobramycin (Nebcin)FDA LinkGeneric 01/2017
1	Biomarkers (Surrogate Marker)IBA 02/2013
1	chitosan lactateIBA 02/2013
1	ChitosanIBA 02/2013
1	polystyrene-block-poly(methyl methacrylate)IBA 12/2006
1	SolutionsIBA 12/2005

Therapy/Procedure

2	Therapeutics 01/2018 - 01/2017
1	Contraindications 01/2017